β-Amyloid fibrils induce tau phosphorylation and loss of microtubule binding

No abstract is available for this paper.

• Publication year

  1995

• Venue

  Neuron

• Publication date

  1995-04-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/0896-6273(95)90232-5
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Beta-amyloid neurotoxicity requires fibril formation and is inhibited by congo red.

  1994cited by this paper
• Biopsy-derived adult human brain tau is phosphorylated at many of the same sites as Alzheimer's disease paired helical filament tau.

  1994cited by this paper
• An increased percentage of long amyloid beta protein secreted by familial amyloid beta protein precursor (beta APP717) mutants.

  1994cited by this paper
• An important role of heparan sulfate proteoglycan (perlecan) in a model system for the deposition and persistence of fibrillar aβ-amyloid in rat brain

  1994cited by this paper
• Role of abnormally phosphorylated tau in the breakdown of microtubules in Alzheimer disease.

  1994cited by this paper
• Pancreatic islet cell toxicity of amylin associated with type-2 diabetes mellitus

  1994cited by this paper
• Alzheimer disease A68 proteins injected into rat brain induce codeposits of beta-amyloid, ubiquitin, and alpha 1-antichymotrypsin.

  1993cited by this paper
• Tau protein kinase I is essential for amyloid beta-protein-induced neurotoxicity.

  1993cited by this paper
• Neurotoxicity of Human Amylin in Rat Primary Hippocampal Cultures: Similarity to Alzheimer's Disease Amyloid‐β Neurotoxicity

  1993cited by this paper
• The extent of phosphorylation of fetal tau is comparable to that of PHF-tau from Alzheimer paired helical filaments.

  1993cited by this paper
• Neurotoxicity of a prion protein fragment

  1993cited by this paper
• Calcium-destabilizing and neurodegenerative effects of aggregated beta-amyloid peptide are attenuated by basic FGF.

  1993cited by this paper
• Phosphorylation of Ser262 strongly reduces binding of tau to microtubules: distinction between PHF-like immunoreactivity and microtubule binding.

  1993cited by this paper
• τ in Paired Helical Filaments Is Functionally Distinct from Fetal τ: Assembly Incompetence of Paired Helical Filament‐τ

  1993cited by this paper
• Generation of beta-amyloid in the secretory pathway in neuronal and nonneuronal cells.

  1993cited by this paper
• Release of excess amyloid beta protein from a mutant amyloid beta protein precursor.

  1993cited by this paper
• Amyloid β-protein stimulates casein kinase I and casein kinase II activities

  1993cited by this paper
• Cellular processing of β-amyloid precursor protein and the genesis of amyloid β-peptide

  1993cited by this paper
• Functional studies of Alzheimer's disease tau protein

  1993cited by this paper
• Tau Protein and the Neurofibrillary Pathology of Alzheimer's Disease

  1993cited by this paper
• Abnormal tau phosphorylation at Ser396 in Alzheimer's disease recapitulates development and contributes to reduced microtubule binding.

  1993cited by this paper
• β‐Amyloid Neurotoxicity in Human Cortical Culture Is Not Mediated by Excitotoxins

  1993cited by this paper
• The abnormal phosphorylation of tau protein at Ser-202 in Alzheimer disease recapitulates phosphorylation during development.

  1993cited by this paper
• In vivo phosphorylation sites in fetal and adult rat tau.

  1993cited by this paper
• Tau as a marker for Alzheimer's disease.

  1993cited by this paper
• Protein sequence and mass spectrometric analyses of tau in the Alzheimer's disease brain.

  1992cited by this paper
• Amyloid β-peptide is produced by cultured cells during normal metabolism

  1992cited by this paper
• Fetal‐Type Phosphorylation of the τ in Paired Helical Filaments

  1992cited by this paper
• Mutation of the β-amyloid precursor protein in familial Alzheimer's disease increases β-protein production

  1992cited by this paper
• Isolation and quantification of soluble Alzheimer's β-peptide from biological fluids

  1992cited by this paper
• Immunological and conformational characterization of a phosphorylated immunodominant epitope on the paired helical filaments found in Alzheimer's disease

  1992cited by this paper
• Hydrofluoric acid-treated tau PHF proteins display the same biochemical properties as normal tau.

  1992cited by this paper
• The disordered neuronal cytoskeleton in Alzheimer's disease.

  1992cited by this paper
• Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease

  1992cited by this paper
• Production of the Alzheimer amyloid beta protein by normal proteolytic processing.

  1992cited by this paper
• The switch of tau protein to an Alzheimer‐like state includes the phosphorylation of two serine‐proline motifs upstream of the microtubule binding region.

  1992cited by this paper
• beta-Amyloid induces neuritic dystrophy in vitro: similarities with Alzheimer pathology.

  1992cited by this paper
• Methodological variables in the assessment of beta amyloid neurotoxicity.

  1992cited by this paper
• In vitro aging of ß-amyloid protein causes peptide aggregation and neurotoxicity ☆

  1991cited by this paper
• Action of amyloid beta-protein on protein kinase C activity.

  1991cited by this paper
• A68: a major subunit of paired helical filaments and derivatized forms of normal Tau.

  1991cited by this paper
• Physical basis of cognitive alterations in alzheimer's disease: Synapse loss is the major correlate of cognitive impairment

  1991cited by this paper
• Localization of the Alz-50 epitope in recombinant human microtubule-associated protein tau.

  1991cited by this paper
• Structural stability of paired helical filaments requires microtubule-binding domains of tau: a model for self-association.

  1991cited by this paper
• β-Amyloid and the pathogenesis of alzheimer's disease

  1991cited by this paper
• Mapping of the Alz 50 epitope in microtubule‐associated proteins tau

  1990cited by this paper
• Neurotrophic and neurotoxic effects of amyloid beta protein: reversal by tachykinin neuropeptides.

  1990cited by this paper
• A preparation of Alzheimer paired helical filaments that displays distinct tau proteins by polyacrylamide gel electrophoresis.

  1990cited by this paper
• Microtubular reorganization and dendritic growth response in alzheimer's disease

  1989cited by this paper
• Massive somatodendritic sprouting of cortical neurons in Alzheimer's disease.

  1988cited by this paper
• Epitopes that span the tau molecule are shared with paired helical filaments.

  1988cited by this paper
• Axonal disruption and aberrant localization of tau protein characterize the neuropil pathology of Alzheimer's disease

  1987cited by this paper
• The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor

  1987cited by this paper
• Abnormal phosphorylation of the microtubule-associated protein? (tau) in Alzheimer cytoskeletal pathology

  1987cited by this paper
• Microtubule-associated protein tau (tau) is a major antigenic component of paired helical filaments in Alzheimer disease.

  1986cited by this paper
• Neurofibrillary tangles of Alzheimer disease share antigenic determinants with the axonal microtubule-associated protein tau (tau)

  1986cited by this paper
• A neuronal antigen in the brains of Alzheimer patients.

  1986cited by this paper
• Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology.

  1986cited by this paper
• Immunocytochemical localization of tubulin and microtubule-associated protein 2 during the development of hippocampal neurons in culture

  1986cited by this paper
• The distribution of tau in the mammalian central nervous system

  1985cited by this paper
• Microtubule assembly using the microtubule-associated protein MAP-2 prepared in defined states of phosphorylation with protein kinase and phosphatase.

  1983cited by this paper
• A taxol-dependent procedure for the isolation of microtubules and microtubule-associated proteins (MAPs)

  1982cited by this paper
• Separation of tubulin from microtubule-associated proteins on phosphocellulose. Accompanying alterations in concentrations of buffer components.

  1979cited by this paper

• Comparative Spectroscopic Investigation of Amyloid Beta Peptides Spin-Labeled with MTSL and PROF

  2026cites this paper
• Mutant TDP-43 drives impairments in axonal transport and glycolysis in a mouse stem-cell-derived motor neuron model of amyotrophic lateral sclerosis (ALS)

  2026cites this paper
• Biofluid biomarkers in Alzheimer’s disease and other neurodegenerative dementias

  2026cites this paper
• Ceftriaxone ameliorates tau phosphorylation and mislocalization in APP/PS1 AD mice by inhibiting endoplasmic reticulum stress.

  2025cites this paper
• Cell-specific copper dyshomeostasis mechanism in Alzheimer’s disease

  2025cites this paper
• Neuroprotective effects of SGLT2 inhibitors empagliflozin and dapagliflozin on Aβ1–42-induced neurotoxicity and neuroinflammation in cellular models of Alzheimer's disease

  2025cites this paper
• A human neuron Alzheimer’s disease model reveals barriers to senolytic translatability

  2025cites this paper
• History of Alzheimer's Disease Research Centers: From inception in 1984 to evolution beyond 2025

  2025cites this paper
• Association and multimodal model of retinal and blood-based biomarkers for detection of preclinical Alzheimer’s disease

  2025cites this paper
• SARS-CoV-2 infection of human cortical cells is influenced by the interaction between aneuploidy and biological sex: insights from a Down syndrome in vitro model

  2025cites this paper
• Voglibose Attenuates Amyloid Beta–Induced Memory Deficits in a Rodent Model: A Potential Alzheimer’s Therapy via Wnt Signaling Modulation

  2025cites this paper
• Mendelian Randomization Reveals Unidirectional Links Between Amyloid-β and Tau in Alzheimer’s Disease

  2025cites this paper
• Second-generation anti-amyloid monoclonal antibodies for Alzheimer’s disease: current landscape and future perspectives

  2025cites this paper
• Phosphorylated tau exhibits antimicrobial activity capable of neutralizing herpes simplex virus 1 infectivity in human neurons.

  2025cites this paper
• The Amyloid Cascade Hypothesis: A Conclusion in Search of Support.

  2024cites this paper
• Clarifying the association of CSF Aβ, tau, BACE1, and neurogranin with AT(N) stages in Alzheimer disease

  2024cites this paper
• Identification of Flavonoids-based HITS to Inhibit GSK3β Activity: An In Silico and In Vitro Analysis

  2024cites this paper
• Extracellular vesicles from hiPSC-derived NSCs protect human neurons against Aβ-42 oligomers induced neurodegeneration, mitochondrial dysfunction and tau phosphorylation

  2024cites this paper
• Exploring the effect of gut microbiome on Alzheimer's disease

  2024cites this paper
• Carboxylated Zn-phthalocyanine attenuates brain Aβ in AD model mouse.

  2024cites this paper
• 9‐Methylfascaplysin Prevents Neuroinflammation and Synaptic Damage via Cell‐Specific Inhibition of Kinases in APP/PS1 Transgenic Mice

  2024cites this paper
• Potential Mechanisms of Tunneling Nanotube Formation and Their Role in Pathology Spread in Alzheimer’s Disease and Other Proteinopathies

  2024cites this paper
• Proposed mechanisms of tau: relationships to traumatic brain injury, Alzheimer’s disease, and epilepsy

  2024cites this paper
• Regulation of presynaptic homeostatic plasticity by glial signalling in Alzheimer's disease

  2024cites this paper
• Aberrant accumulation of age- and disease-associated factors following neural probe implantation in a mouse model of Alzheimer’s disease

  2023cites this paper
• Mechanisms and structure-activity relationships of polysaccharides in the intervention of Alzheimer's disease: A review.

  2023cites this paper
• Coconut oil ameliorates behavioral and biochemical alterations induced by D-GAL/AlCl3 in rats.

  2023cites this paper
• Effects of anti‐tau immunotherapy on reactive microgliosis, cerebral endotheliopathy, and cognitive function in an experimental model of cerebral malaria

  2023cites this paper
• Re-Arranging the Puzzle between the Amyloid-Beta and Tau Pathology: An APP-Centric Approach

  2023cites this paper
• The pathomimetic oAβ25-35 model of Alzheimer's disease: Potential for screening of new therapeutic agents.

  2023cites this paper
• Effects of Scrophularia buergeriana Extract (Brainon®) on Aging-Induced Memory Impairment in SAMP8 Mice

  2023cites this paper
• Evaluation of Pathological Perspectives Related to Alzheimers Disease

  2023cites this paper
• Identification of small molecules and related targets that modulate tau pathology in a seeded primary neuron model

  2023cites this paper
• Sleep Disturbance and Alzheimer’s Disease: The Glial Connection

  2022cites this paper
• Involvement of molecular chaperone in protein-misfolding brain diseases.

  2022cites this paper
• Consequences of Hyperphosphorylated Tau in the Locus Coeruleus on Behavior and Cognition in a Rat Model of Alzheimer’s Disease

  2022cites this paper
• Age-dependent microstructure alterations in 5xFAD mice by high-resolution diffusion tensor imaging

  2022cites this paper
• Linking Diabetes to Alzheimer’s Disease: Potential Roles of Glucose Metabolism and Alpha-Glucosidase

  2022cites this paper
• Oxidative Stress-Induced Damage to the Developing Hippocampus Is Mediated by GSK3 b

  2022cites this paper
• Clusterin Binding Modulates the Aggregation and Neurotoxicity of Amyloid-β(1–42)

  2022cites this paper
• Oxidative Stress-Induced Damage to the Developing Hippocampus Is Mediated by GSK3β

  2022cites this paper
• Microglial activation in Alzheimer's disease: The role of flavonoids and microRNAs

  2022cites this paper
• Endothelial Progenitor Cells and Vascular Alterations in Alzheimer’s Disease

  2022cites this paper
• Naturally Occurring Antioxidant Therapy in Alzheimer’s Disease

  2022cites this paper
• Alzheimer’s Disease Biomarkers Revisited From the Amyloid Cascade Hypothesis Standpoint

  2022cites this paper
• Interacting Models of Amyloid-β and Tau Proteins: An Approach to Identify Drug Targets in Alzheimer’s Disease

  2021cites this paper
• New Approaches to Profile the Microbiome for Treatment of Neurodegenerative Disease

  2021cites this paper
• Dimethyl fumarate abridged tauo-/amyloidopathy in a D-Galactose/ovariectomy-induced Alzheimer's-like disease: Modulation of AMPK/SIRT-1, AKT/CREB/BDNF, AKT/GSK-3β, Adiponectin/Adipo1R, and NF-κB/IL-1β/ROS trajectories.

  2021cites this paper
• Molecular Modeling Studies of C-Glycosylfavone Derivatives as GSK-3β Inhibitors Based on QSAR and Docking Analysis

  2021cites this paper
• Atomic Level Investigations of Early Aggregation of Tau43 in Water II . Tau43‐Aβ42 vs. Tau43‐ Tau43 Dimerizations

  2021cites this paper
• Nonphosphorylated tau slows down Aβ1–42 aggregation, binds to Aβ1–42 oligomers, and reduces Aβ1–42 toxicity

  2021cites this paper
• The role of neuropeptide somatostatin in the brain and its application in treating neurological disorders

  2021cites this paper
• Consequences of endogenous and virally-induced hyperphosphorylated tau on behavior and cognition in a rat model of Alzheimer’s disease

  2021cites this paper
• The Potential Role of Cytokines and Growth Factors in the Pathogenesis of Alzheimer’s Disease

  2021cites this paper
• Human Dental Pulp Stem Cells Display a Potential for Modeling Alzheimer Disease-Related Tau Modifications

  2021cites this paper
• N-methyl-d-aspartate receptor blockade reduces plasticity-related tau expression and phosphorylation of tau at Ser416 residue but not Thr231 residue

  2021cites this paper
• Oligomeric amyloid-β induces early and widespread changes to the proteome in human iPSC-derived neurons

  2020cites this paper
• Molecular Mechanisms of Metal Toxicity in the Pathogenesis of Alzheimer’s Disease

  2020cites this paper
• Accumulation of neurofibrillary tangles and activated microglia is associated with lower neuron densities in the aphasic variant of Alzheimer’s disease

  2020cites this paper
• Geraniin Protects PC12 Cells Against Aβ25–35-Mediated Neuronal Damage: Involvement of NF-κB and MAPK Signaling Pathways

  2020cites this paper
• Hsp90-interacting co-chaperones and their family proteins in tau regulation: Introducing a novel role for Cdc37L1.

  2020cites this paper
• Moderate Overexpression of Tau in Drosophila Exacerbates Amyloid-β-Induced Neuronal Phenotypes and Correlates with Tau Oligomerization

  2020cites this paper
• Molecular Mechanisms of Metal Toxicity in the Pathogenesis of Alzheimer’s Disease

  2020cites this paper
• Role of tau protein in Alzheimer's disease: The prime pathological player.

  2020cites this paper
• Ubiquitin, Autophagy and Neurodegenerative Diseases

  2020cites this paper
• A human induced pluripotent stem cell‐derived cortical neuron human‐on‐a chip system to study Aβ42 and tau‐induced pathophysiological effects on long‐term potentiation

  2020cites this paper
• Progress toward Alzheimer's disease treatment: Leveraging the Achilles' heel of Aβ oligomers?

  2020cites this paper
• The Role of Mitochondrial Impairment in Alzheimer´s Disease Neurodegeneration: The Tau Connection

  2020cites this paper
• One or more β-amyloid(s)? New insights into the prion-like nature of Alzheimer's disease.

  2020cites this paper
• Arsenic Exposure and Compromised Protein Quality Control.

  2020cites this paper
• What causes neurodegenerative disease?

  2020cites this paper
• The Formyl Peptide Receptor 2 Regulates Microglial Phenotype Through Immunometabolism: Implications for Alzheimer’s Disease

  2019influential citation
• How stress mediators can cumulatively contribute to Alzheimer’s disease An allostatic load approach

  2019cites this paper
• The Role of Trace Metals in Alzheimer’s Disease

  2019cites this paper
• Malva parviflora extract ameliorates the deleterious effects of a high fat diet on the cognitive deficit in a mouse model of Alzheimer’s disease by restoring microglial function via a PPAR-γ-dependent mechanism

  2019cites this paper
• Amyloid-β and Tau at the Crossroads of Alzheimer's Disease.

  2019cites this paper
• QSAR study of isonicotinamides derivatives as Alzheimr's disease inhibitors using PLS-R and ANN methods

  2019cites this paper
• Carbon nanomaterials and amyloid‐beta interactions: potentials for the detection and treatment of Alzheimer's disease?

  2019cites this paper
• Liquid-Liquid Phase Separation of Tau Protein in Neurobiology and Pathology.

  2019cites this paper
• Oxidative Potential of Particulate Matter: A Prospective Measure to Assess PM Toxicity

  2019cites this paper
• Regulation of Diabetes: a Therapeutic Strategy for Alzheimer's Disease?

  2019cites this paper
• Impaired tau–microtubule interactions are prevalent among pathogenic tau variants arising from missense mutations

  2019cites this paper
• Neuroscientific Research for Management of Dementia

  2019cites this paper
• The fruit of Crataegus pinnatifida ameliorates memory deficits in β-amyloid protein-induced Alzheimer's disease mouse model.

  2019cites this paper
• Neurotrophin receptor p75 mediates amyloid β-induced tau pathology.

  2019cites this paper
• Knockout of p75 neurotrophin receptor attenuates the hyperphosphorylation of Tau in pR5 mouse model

  2019cites this paper
• Aβ Seeding as a Tool to Study Cerebral Amyloidosis and Associated Pathology

  2019cites this paper
• Role of Neuroimaging Modality in the Assessment of Oxidative Stress in Brain: A Comprehensive Review.

  2019cites this paper
• Tau Biology

  2019cites this paper
• Ginsenoside Re Inhibits ROS/ASK-1 Dependent Mitochondrial Apoptosis Pathway and Activation of Nrf2-Antioxidant Response in Beta-Amyloid-Challenged SH-SY5Y Cells

  2019cites this paper
• Tauopathy: A common mechanism for neurodegeneration and brain aging.

  2019cites this paper
• Multi-functional neuroprotective activity of neohesperidin dihydrochalcone: a novel scaffold for Alzheimer's disease therapeutics identified via drug repurposing screening

  2018cites this paper
• Inhibitory effect of the leaves and stems of Actinidia arguta on Aβ (25-35)-induced neuronal cell death and memory impairment

  2018cites this paper
• Ginsenoside Rg1 and Acori Graminei Rhizoma Attenuates Neuron Cell Apoptosis by Promoting the Expression of miR-873-5p in Alzheimer’s Disease

  2018cites this paper
• Dependence of the Formation of Tau and Aβ Peptide Mixed Aggregates on the Secondary Structure of the N-Terminal Region of Aβ.

  2018cites this paper
• Construction of Quenchbodies to detect and image amyloid β oligomers.

  2018cites this paper
• Effects of celastrol on Tau hyperphosphorylation and expression of HSF‐1 and HSP70 in SH‐SY5Y neuroblastoma cells induced by amyloid‐β peptides

  2018cites this paper
• Pathogenic Mechanisms of Heavy Metal Induced-Alzheimer’s Disease

  2018cites this paper
• Synthesis and characterisation of novel phenanthroline quinone derivatives and their evaluation as Alzheimer's disease therapeutic active ingredients

  2018cites this paper
• Targeting Tyro3 ameliorates a model of PGRN-mutant FTLD-TDP via tau-mediated synaptic pathology

  2018cites this paper